News
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
4d
News-Medical.Net on MSNMIT develops implantable device to automatically release emergency glucagonFor people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels ...
MIT engineers have developed a tiny implantable device that could revolutionize emergency treatment for people with Type 1 ...
MIT engineers developed an implantable reservoir that can remain under the skin and be triggered to release glucagon when ...
For individuals with type 1 diabetes – an autoimmune condition – maintaining stable blood sugar is a constant challenge. Rapid-acting insulin must be administered, either through ...
Does using Ozempic cause brain fog? It depends on who you ask. This article takes a closer look at what’s going on with ...
We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...
Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.
New data from The Ohio State University Wexner Medical Center Comprehensive Transplant Center shows obese patients with end stage kidney disease and diabetes can safely use weight loss injections to ...
4d
TipRanks on MSNMetaVia doses first patient in 48 mg MAD cohort of its Phase 1 trialMetaVia (MTVA) announced dosing of the first patient in the 48 mg, multiple ascending dose, MAD, cohort of its Phase 1 clinical trial of DA-1726, ...
SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.
Digging Into HepatoBurn Reviews, Ingredients, Side Effects & Why This Liver-Focused Metabolism Formula Is Dominating 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results